Nirmatrelvir is an antiviral medication developed by Pfizer that acts as an orally active 3C-like protease inhibitor. It is part of the nirmatrelvir/ritonavir combination sold under the brand name Paxlovid and is used to treat COVID-19. Nirmatrelvir works by inhibiting the 3C-like protease enzyme that SARS-CoV-2, the virus responsible for COVID-19, requires for replication. Ritonavir is included to boost the levels of nirmatrelvir by inhibiting its metabolism.
Parent: Nirmatrelvir
Parent: Nirmatrelvir
Parent: Nirmatrelvir
Parent: Nirmatrelvir
Parent: Nirmatrelvir
Parent: Nirmatrelvir
Parent: Nirmatrelvir
Impurities in Nirmatrelvir can arise due to synthesis processes, degradation, or storage conditions. Regulatory authorities like the FDA, ICH, and EMA enforce strict impurity limits to ensure the drug’s safety and efficacy.
Process-Related Impurities
Degradation Impurities
Elemental Impurities
Analytical Techniques for Impurity Detection
The downsides of taking Paxlovid include gastrointestinal side effects such as nausea, diarrhea, and altered taste (dysgeusia). Additionally, it has significant drug-drug interactions due to the ritonavir component, which can inhibit the metabolism of other medications.
Yes, it is okay to start Paxlovid at night as long as you follow the prescribed dosing schedule. Paxlovid should be taken every 12 hours consistently for five days.
Paxlovid has multiple drug interactions due to the ritonavir component, which inhibits CYP3A4 enzymes. Medications to avoid include statins (like simvastatin), antiarrhythmics (like amiodarone), certain antiepileptics (like carbamazepine), and some sedatives (like midazolam). Always consult a healthcare provider for a comprehensive list.
No, it is not recommended to stop Paxlovid after 3 days. To ensure effectiveness and prevent viral rebound, the full 5-day course must be completed as prescribed.
